Salivary biomarkers associated with gingivitis and response to therapy

Journal of Periodontology

Volumn 85, Issue 8, 2014, Pages

  Syndergaard, Ben ^a   Al Sabbagh, Mohanad ^a   Kryscio, Richard J ^a   Xi, Jing ^a   Ding, Xiuhua ^a   Ebersole, Jeffrey L ^a   Miller, Craig S ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Biological markers; Gingivitis; Metalloproteases; Periodontitis; Prostaglandins; Saliva

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; CCL3 PROTEIN, HUMAN; CHLORHEXIDINE; IL6 PROTEIN, HUMAN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MMP8 PROTEIN, HUMAN; MOUTHWASH; NEUTROPHIL COLLAGENASE; PROSTAGLANDIN E2; TOPICAL ANTIINFECTIVE AGENT;

ADULT; CASE CONTROL STUDY; CHEMISTRY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GINGIVA; GINGIVITIS; HUMAN; IMMUNOLOGY; LONGITUDINAL STUDY; MALE; METABOLISM; PERIODONTAL POCKET; PERIODONTICS; PREVENTIVE DENTISTRY; PROCEDURES; SALIVA; TOOTH PLAQUE; YOUNG ADULT;

ADULT; ANTI-INFECTIVE AGENTS, LOCAL; BIOMARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL3; CHLORHEXIDINE; DENTAL PLAQUE INDEX; DENTAL PROPHYLAXIS; DENTAL SCALING; DINOPROSTONE; FEMALE; FOLLOW-UP STUDIES; GINGIVA; GINGIVITIS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; MATRIX METALLOPROTEINASE 8; MOUTHWASHES; PERIODONTAL INDEX; PERIODONTAL POCKET; SALIVA; YOUNG ADULT;

EID: 84905485302     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2014.130696     Document Type: Article

References (50)

1. Loe H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol 1965;36:177-187.
2. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-1820.
3. Albandar JM, Kingman A. Gingival recession, gingival bleeding, and dental calculus in adults 30 years of age and older in the United States, 1988-1994. J Periodontol 1999;70:30-43.
4. Tomar SL, Asma S. Smoking-attributable periodontitis in the United States: Findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol 2000;71:743-751.
5. Schätzle M, Faddy MJ, Cullinan MP, et al. The clinical course of chronic periodontitis: V. Predictive factors in periodontal disease. J Clin Periodontol 2009;36:365-371.
6. Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol 1996;1:821-878.
7. Van Dyke TE, Sheilesh D. Risk factors for periodontitis. J Int Acad Periodontol 2005;7:3-7.
8. Trombelli L. Susceptibility to gingivitis: A way to predict periodontal disease? Oral Health Prev Dent 2004;2(Suppl.1):265-269.
9. Grigoriadou ME, Koutayas SO, Madianos PN, Strub JR. Interleukin-1 as a genetic marker for periodontitis: Review of the literature. Quintessence Int 2010;41:517-525.
10. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: Assembling the players. Periodontol 2000 1997;14:33-53.
11. Ebersole JL, Dawson DR 3rd, Morford LA, Peyyala R, Miller CS, Gonzaléz OA. Periodontal disease immunology: 'Double indemnity' in protecting the host. Periodontol 2000 2013;62:163-202.
12. Yucel-Lindberg T, Båge T. Inflammatory mediators in the pathogenesis of periodontitis. Expert Rev Mol Med 2013;15:e7.
13. Miller CS, King CP Jr., Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal disease: A cross-sectional study. J Am Dent Assoc 2006;137:322-329.
14. Sorsa T, Mäntylä P, Rönkä H, et al. Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann N Y Acad Sci 1999;878:130-140.
15. Miller CS, Foley JD, Bailey AL, et al. Current developments in salivary diagnostics. Biomarkers Med 2010;4:171-189.
16. Kinney JS, Ramseier CA, Giannobile WV. Oral fluidbased biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci 2007;1098:230-251.
17. Giannobile WV, Beikler T, Kinney JS, Ramseier CA, Morelli T, Wong DT. Saliva as a diagnostic tool for periodontal disease: Current state and future directions. Periodontol 2000 2009;50:52-64.
18. Fine DH, Markowitz K, Furgang D, et al. Macrophage inflammatory protein-1alpha: A salivary biomarker of bone loss in a longitudinal cohort study of children at risk for aggressive periodontal disease? J Periodontol 2009;80:106-113.
19. Prakasam S, Srinivasan M. Evaluation of salivary biomarker profiles following non-surgical management of chronic periodontitis. Oral Dis 2013;20:171-177.
20. Henskens YM, Van Der Velden U, Veerman EC, Nieuw Amerongen AV. Protein, albumin and cystatin concentrations in saliva of healthy subjects and of patients with gingivitis or periodontitis. J Periodontal Res 1993;28:43-48.
21. Shaila M, Pai GP, Shetty P. Salivary protein concentration, flow rate, buffer capacity and pH estimation: A comparative study among young and elderly subjects, both normal and with gingivitis and periodontitis. J Indian Soc Periodontol 2013;17:42-46.
22. Lee A, Ghaname CB, Braun TM, et al. Bacterial and salivary biomarkers predict the gingival inflammatory profile. J Periodontol 2012;83:79-89.
23. Heasman PA, Collins JG, Offenbacher S. Changes in crevicular fluid levels of interleukin-1 beta, leukotriene B4, prostaglandin E2, thromboxane B2 and tumour necrosis factor alpha in experimental gingivitis in humans. J Periodontal Res 1993;28:241-247.
24. Andriankaja OM, Barros SP, Moss K, et al. Levels of serum interleukin (IL)-6 and gingival crevicular fluid of IL-1beta and prostaglandin E (2) among non-smoking subjects with gingivitis and type 2 diabetes. J Periodontol 2009;80:307-316.
25. Löe H. The gingival index, the plaque index and the retention index systems. J Periodontol 1967;38(Suppl. 6):610-616.
26. Worsfold M, Powell DE, Jones TJ, Davie MW. Assessment of urinary bone markers for monitoring treatment of osteoporosis. Clin Chem 2004;50:2263-2270.
27. Li Y, Lee S, Hujoel P, et al. Prevalence and severity of gingivitis in American adults. AmJ Dent 2010;23:9-13.
28. Giannobile WV, McDevitt JT, Niedbala RS, Malamud D. Translational and clinical applications of salivary diagnostics. Adv Dent Res 2011;23:375-380.
29. Al-Sabbagh M, Alladah A, Lin Y, et al. Bone remodelingassociated salivary biomarker MIP-1a distinguishes periodontal disease from health. J Periodontal Res 2012;47:389-395.
30. Christodoulides N, Floriano PN, Miller CS, et al. Labona-chip methods for point-of-care measurements of salivary biomarkers of periodontitis. Ann N Y Acad Sci 2007;1098:411-428.
31. Sánchez GA, Miozza VA, Delgado A, Busch L. Salivary IL-1b and PGE2 as biomarkers of periodontal status, before and after periodontal treatment. J Clin Periodontol 2013;40:1112-1117.
32. Rathnayake N, Akerman S, Klinge B, et al. Salivary biomarkers of oral health: A cross-sectional study. J Clin Periodontol 2013;40:140-147.
33. Kaushik R, Yeltiwar RK, Pushpanshu K. Salivary interleukin-1b levels in patients with chronic periodontitis before and after periodontal phase I therapy and healthy controls: A case-control study. J Periodontol 2011;82:1353-1359.
34. Goodson JM, Dewhirst FE, Brunetti A. Prostaglandin E2 levels and human periodontal disease. Prostaglandins 1974;6:81-85.
35. Ebersole JL, Schuster JL, Stevens J, et al. Patterns of salivary analytes provide diagnostic capacity for distinguishing chronic adult periodontitis from health. J Clin Immunol 2013;33:271-279.
36. Thomas MV, Branscum A, Miller CS, Ebersole J, Al-Sabbagh M, Schuster JL. Within-subject variability in repeated measures of salivary analytes in healthy adults. J Periodontol 2009;80:1146-1153.
37. Kinney JS, Morelli T, Braun T, et al. Saliva/pathogen biomarker signatures and periodontal disease progression. J Dent Res 2011;90:752-758.
38. Zhou M, Meng HX, Zhao YB, Chen ZB. Changes of four proinflammatory proteins in whole saliva during experimental gingivitis. Chin J Dent Res 2012;15:121-127.
39. Deinzer R, Weik U, Kolb-Bachofen V, Herforth A. Comparison of experimental gingivitis with persistent gingivitis: Differences in clinical parameters and cytokine concentrations. J Periodontal Res 2007;42:318-324.
40. Trombelli L, Scapoli C, Carrieri A, Giovannini G, Calura G, Farina R. Interleukin-1 beta levels in gingival crevicular fluid and serum under naturally occurring and experimentally induced gingivitis. J Clin Periodontol 2010;37:697-704.
41. Trombelli L, Tatakis DN, Scapoli C, Bottega S, Orlandini E, Tosi M. Modulation of clinical expression of plaque-induced gingivitis. II. Identification of "highresponder" and "low-responder" subjects. J Clin Periodontol 2004;31:239-252.
42. Sexton WM, Lin Y, Kryscio RJ, Dawson DR 3rd, Ebersole JL, Miller CS. Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol 2011;38:434-441.
43. Vassiliou E, Jing H, Ganea D. Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells. Cell Immunol 2003;223:120-132.
44. Harizi H, Norbert G. Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells. Cell Immunol 2004;228:99-109.
45. Offenbacher S, Heasman PA, Collins JG. Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64(Suppl. 5):432-444.
46. Jing H, Vassiliou E, Ganea D. Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells. J Leukoc Biol 2003;74:868-879.
47. Keinan D, Leigh NJ, Nelson JW, De Oleo L, Baker OJ. Understanding resolvin signaling pathways to improve oral health. Int J Mol Sci 2013;14:5501-5518.
48. Freire MO, Van Dyke TE. Natural resolution of inflammation. Periodontol 2000 2013;63:149-164.
49. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349-361.
50. Offenbacher S, Odle BM, Van Dyke TE. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodontal Res 1986;21:101-112.